Lamivudine & Zidovudine bulk supplier for pharma manufacturers

Lamivudine & Zidovudine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Lamivudine 150 mg + Zidovudine 300 mg

Reference Brands: Combivir®(US/ EU)

Category: Anti Viral

Lamivudine & Zidovudine is available in Tablet and strengths such as Lamivudine 150 mg + Zidovudine 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lamivudine & Zidovudine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lamivudine & Zidovudine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Lamivudine & Zidovudine Tablets are a fixed-dose combination of two key NRTIs used in the management of HIV-1 infection. Each tablet contains Lamivudine 150 mg and Zidovudine 300 mg, offering dual-action antiviral activity in a convenient dosing format. Available under brands like Combivir®, this formulation is widely used in global HIV treatment protocols. Through PharmaB2B platforms, healthcare providers and procurement agencies can access bulk supplies from WHO-GMP and USFDA-approved manufacturers. Ideal for tenders, NGOs, and institutional buyers, this ARV combo supports consistent, cost-effective treatment. Connect with trusted suppliers to ensure high-quality antiretrovirals and uninterrupted patient care.

Frequently Asked Questions

Yes, Lamivudine & Zidovudine is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lamivudine & Zidovudine is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Zanamivir

Strength:
5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details
Oseltamivir Phosphate Capsule

Strength:
Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details
Amantadine

Strength:
Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details
Glecaprevir + Pibrentasvir

Strength:
Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.